Table: begin end state 1 29 cytoplasmic 30 50 transmembrane 51 61 non-cytoplasmic 62 82 transmembrane 83 95 cytoplasmic 96 114 transmembrane 115 119 non-cytoplasmic 120 142 transmembrane 143 153 cytoplasmic 154 176 transmembrane 177 187 non-cytoplasmic 188 209 transmembrane 210 256 cytoplasmic 257 278 transmembrane 279 297 non-cytoplasmic 298 316 transmembrane 317 322 cytoplasmic 323 340 transmembrane 341 345 non-cytoplasmic 346 366 transmembrane 367 376 cytoplasmic 377 401 transmembrane 402 410 non-cytoplasmic 411 432 transmembrane 433 442 cytoplasmic
Input: >HSERO_RS05735 VETPQPAASATGAAAPTVLQQAVAKIKQRVLPLFVIMFIVNYIDRVNIGFVRSHLATDVG IGTAAYGLGAGLFFVGYALFEVPSNLLLQRFGAKAWLTRIMATWGLAATAMAFVNSETTF YVLRFLLGAAEAGFFPGVIYYFTQWLPASERGRAMAIFLSGSALASILSGPISGGLLQID GGGLQGWQWMFIIEGMASVLLCGFVWFWLDSMPADAKWLTAQERSAITRAIVDEQAERMK HQPAQVSPRQLLRDPQILIFCFIYFSISLTIYGATFWLPSIIRKMGSFSDFQVGLFNSIP WLISIVAMYAFAALAARFKHQQAWAATALVIAAAGMFASTFGNSVYAFVSICFAAVGFKA ASSLFWPLPQAYLDARIAAGVIALINSIGNLGGFVAPTAFGFLEQRTGSIQGGLMGLAIT SLVAAGVVFLARSGPGATRRPR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server